^
Association details:
| Biomarker: | EGFR L858R |
|---|---|
| Cancer: | Lung Non-Squamous Non-Small Cell Cancer |
| Drug: | Rybrevant (amivantamab-vmjw) (EGFR inhibitor, c-MET inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
12/21/2023
Excerpt:
Non-Small Cell Lung Cancer: EGFR Exon 19 Deletion or Exon 21 L858R…Subsequent therapy...Amivantamab-vmjw + carboplatin + pemetrexed (nonsquamous)...
Secondary therapy:
carboplatin + pemetrexed
